Compound Detail
CHEMBL128748
DIMETHYLCURCUMIN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL128748 |
| Name | DIMETHYLCURCUMIN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | ZMGUKFHHNQMKJI-CIOHCNBKSA-N |
8
Targets
14
Activities
2
Assay Types
0
PK Parameters
20
Publications
5
Known Names
1
Indications
1
Mechanisms
Molecular Properties
396.4
MW (Da)
4.46
ALogP
6
HBA
1
HBD
74.2
PSA (Ų)
0.38
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Androgen Receptor degrader | DEGRADER | Androgen receptor | ✓ | ✓ |
Indications
Acne Vulgaris
Activity Summary
IC50 13 meas. best 5.96
EC50 1 meas. best 5.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| PC-3 CHEMBL390 | IC50 | 5.96 | 5.4425 | 1100.0 | 4 |
| LNCaP CHEMBL612518 | IC50 | 5.89 | 5.5025 | 1300.0 | 4 |
| SK-OV-3 CHEMBL614925 | IC50 | 5.46 | 5.46 | 3510.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.31 | 5.31 | 4900.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 5.27 | 5.27 | 5400.0 | 1 |
| Molecular identity unknown CHEMBL612546 | EC50 | 5.08 | 5.08 | 8300.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 4.5 | 4.5 | 31500.0 | 1 |
| Human immunodeficiency virus type 1 integrase CHEMBL3471 | IC50 | 4.0 | 4.0 | 100000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24275249 | 10.1016/j.ejmech.2013.10.073 | Molecular identity unknown | 7 |
| 25753330 | 10.1016/j.bmc.2015.02.003 | Epidermal growth factor receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 35786895 | 10.1021/acs.jmedchem.2c00716 | Androgen receptor | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 12408714 | 10.1021/jm020200g | Androgen receptor | 2 |
| 19249204 | 10.1016/j.bmcl.2009.01.104 | LNCaP | 1 |
| 21070043 | 10.1021/jm1004545 | Unchecked | 1 |
| 21601463 | 10.1016/j.bmc.2011.04.055 | Radical scavenging activity | 1 |
| 20060305 | 10.1016/j.bmc.2009.12.045 | HCT-116 | 1 |
| 19249204 | 10.1016/j.bmcl.2009.01.104 | ADMET | 1 |
| 19249204 | 10.1016/j.bmcl.2009.01.104 | MDA-MB-231 | 1 |
| 19249204 | 10.1016/j.bmcl.2009.01.104 | MCF7 | 1 |
| 18678491 | 10.1016/j.bmc.2008.07.054 | Unchecked | 1 |
| 16789753 | 10.1021/jm051043z | PC-3 | 1 |
| 11831895 | 10.1021/jm010399h | Human immunodeficiency virus type 1 integrase | 1 |
| 9767632 | 10.1021/jm9707232 | ADMET | 1 |
| 9767632 | 10.1021/jm9707232 | KB | 1 |
| 9767632 | 10.1021/jm9707232 | MT4 | 1 |
Data from ChEMBL 36 via Core Engine